BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 22751462)

  • 1. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.
    Dulak AM; Schumacher SE; van Lieshout J; Imamura Y; Fox C; Shim B; Ramos AH; Saksena G; Baca SC; Baselga J; Tabernero J; Barretina J; Enzinger PC; Corso G; Roviello F; Lin L; Bandla S; Luketich JD; Pennathur A; Meyerson M; Ogino S; Shivdasani RA; Beer DG; Godfrey TE; Beroukhim R; Bass AJ
    Cancer Res; 2012 Sep; 72(17):4383-93. PubMed ID: 22751462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
    van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
    Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
    Rossi E; Villanacci V; Danesino C; Donato F; Nascimbeni R; Bassotti G
    Rev Esp Enferm Dig; 2011 Dec; 103(12):632-9. PubMed ID: 22217347
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Klempner SJ; Madison R; Pujara V; Ross JS; Miller VA; Ali SM; Schrock AB; Kim ST; Maron SB; Dayyani F; Catenacci DVT; Lee J; Chao J
    Oncologist; 2019 Nov; 24(11):1462-1468. PubMed ID: 31249137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic deletion in 11p15 is a common occurrence in esophageal and gastric adenocarcinoma.
    Moskaluk CA; Rumpel CA
    Cancer; 1998 Jul; 83(2):232-9. PubMed ID: 9669804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.
    Lin L; Prescott MS; Zhu Z; Singh P; Chun SY; Kuick RD; Hanash SM; Orringer MB; Glover TW; Beer DG
    Cancer Res; 2000 Dec; 60(24):7021-7. PubMed ID: 11156406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERBB2 amplifications in esophageal adenocarcinoma.
    Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
    Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts.
    Boonstra JJ; van Marion R; Douben HJ; Lanchbury JS; Timms KM; Abkevich V; Tilanus HW; de Klein A; Dinjens WN
    Genes Chromosomes Cancer; 2012 Mar; 51(3):272-82. PubMed ID: 22081516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA factors in gastrointestinal malignancy.
    Ayanbule F; Belaguli NS; Berger DH
    World J Surg; 2011 Aug; 35(8):1757-65. PubMed ID: 21210118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas.
    Stocks SC; Pratt N; Sales M; Johnston DA; Thompson AM; Carey FA; Kernohan NM
    Genes Chromosomes Cancer; 2001 Sep; 32(1):50-8. PubMed ID: 11477661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Alterations and Targeted Therapy in Gastric and Esophageal Adenocarcinoma.
    Pectasides E
    Clin Ther; 2016 Jul; 38(7):1589-99. PubMed ID: 27041412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy.
    Murugaesu N; Wilson GA; Birkbak NJ; Watkins T; McGranahan N; Kumar S; Abbassi-Ghadi N; Salm M; Mitter R; Horswell S; Rowan A; Phillimore B; Biggs J; Begum S; Matthews N; Hochhauser D; Hanna GB; Swanton C
    Cancer Discov; 2015 Aug; 5(8):821-831. PubMed ID: 26003801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract.
    Albin J; Fahrig L; Siemanowski J; Rehkaemper J; Gebauer F; Zander T; Buettner R; Bruns CJ; Schroeder W; Alakus H; Hieggelke L; Quaas A
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5289-5300. PubMed ID: 36416959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
    Kato S; Okamura R; Baumgartner JM; Patel H; Leichman L; Kelly K; Sicklick JK; Fanta PT; Lippman SM; Kurzrock R
    Clin Cancer Res; 2018 Dec; 24(24):6248-6256. PubMed ID: 30348637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.
    Kadota M; Yang HH; Gomez B; Sato M; Clifford RJ; Meerzaman D; Dunn BK; Wakefield LM; Lee MP
    PLoS One; 2010 Feb; 5(2):e9201. PubMed ID: 20169162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: a study using in-situ hybridization.
    Beuzen F; Dubois S; Fléjou JF
    Histopathology; 2000 Sep; 37(3):241-9. PubMed ID: 10971700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated genomic characterization of oesophageal carcinoma.
    ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Nature; 2017 Jan; 541(7636):169-175. PubMed ID: 28052061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of kinase amplifications in gastric adenocarcinomas.
    Özdemiri M; Öznur M; Çiftçi E; Durak Aras B; Aslan H; Saygili H; Öner KS; Erkasap SM; Özakyol A; Paşaoğlu Ö; Çilingir O; Artan S
    Turk J Med Sci; 2014; 44(3):461-70. PubMed ID: 25558650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss.
    Moskaluk CA; Hu J; Perlman EJ
    Genes Chromosomes Cancer; 1998 Aug; 22(4):305-11. PubMed ID: 9669668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.